Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Net Income (2018 - 2025)

Historic Net Income for Neurogene (NGNE) over the last 5 years, with Q3 2025 value amounting to -$21.1 million.

  • Neurogene's Net Income fell 365.48% to -$21.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.8 million, marking a year-over-year decrease of 2393.35%. This contributed to the annual value of -$75.7 million for FY2024, which is 4376.38% down from last year.
  • According to the latest figures from Q3 2025, Neurogene's Net Income is -$21.1 million, which was down 365.48% from -$23.2 million recorded in Q2 2025.
  • In the past 5 years, Neurogene's Net Income registered a high of -$11.9 million during Q2 2023, and its lowest value of -$23.2 million during Q2 2025.
  • For the 3-year period, Neurogene's Net Income averaged around -$17.8 million, with its median value being -$18.6 million (2024).
  • In the last 5 years, Neurogene's Net Income tumbled by 5713.92% in 2024 and then crashed by 365.48% in 2025.
  • Quarter analysis of 3 years shows Neurogene's Net Income stood at -$14.0 million in 2023, then plummeted by 40.71% to -$19.7 million in 2024, then dropped by 7.35% to -$21.1 million in 2025.
  • Its Net Income stands at -$21.1 million for Q3 2025, versus -$23.2 million for Q2 2025 and -$22.8 million for Q1 2025.